Wireless, Low-Maintenance Transdermal Alcohol Sensor

经皮酒精的测量是一种潜在的非常不引人注目的，廉价和准确的方法， 持续研究研究和实地环境中受试者的酒精消费行为， 监控特殊人群。在电化学传感方面的几项创新技术进展， 工程提出，将导致一种新的透皮酒精传感系统，以测量血液 酒精浓度。拟议中的传感系统将超越目前Giner的专利技术 并构成新的、创新的且可能获得专利的技术。Giner中的新传感器系统 WrisJAS”腕戴式透皮酒精传感器）系列将需要低维护， 佩戴舒适，允许从家中传输数据，更耐篡改， 制造昂贵。它可以透皮检测血液中的酒精含量（10- >400 mg/dl）。商业目标是 以低于1100美元的价格出售完整的酒精监测系统。 拟议的第二阶段计划将继续并扩展第三阶段的成功研究和开发。 我编程。第二阶段的目标是：1）完成额外的改进，以提高性能， 2）开发第二代无线数据传输和自动化数据 分析. 3)设计WrisTAS”7外壳（传感器模块、电子模块和腕带/电缆）4） 在临床环境中评估新的WrisTAS”产品。 商业潜力：连续无创酒精监测仪有许多市场，包括： 1)研究和临床治疗方案。2)为无意识的人准备的急诊室， 丧失能力或无法用力呼气。3)监测有或没有已知的酒精的专业人员 涉及公共安全（航空、核、医疗）的职位问题。4)监控驱动程序， 酒后驾车/酒后驾车定罪。5)刑事司法系统，法院需要监督戒酒的人， 假释、缓刑或软禁的罪犯。

Measurement of transdermal alcohol is potentially a very unobtrusive, inexpensive and accurate way of continuously studying the alcohol consumption behavior of subjects in research and field settings as well as for monitoring special populations. Several innovative technological advances in electrochemical sensing and engineering are proposed that will result in a novel transdermal alcohol sensing system to measure blood alcohol concentration. The proposed sensing system will go beyond the current Giner patented technology and constitute new, innovative, and potentially patentable technology. The new sensor system in the Giner WrisJAS" rWristworn Transdermal Alcohol Sensor) family will require low maintenance, be more comfortable to wear, allow transfer of data from the home, be more resistant to tampering and be less expensive to manufacture. It detects blood alcohol transdermally (10- >400 mg/dl). The commercial goal is to sell the complete alcohol monitoring system for under $1100. The proposed Phase II program will continue and extend the successful research and development in the Phase I program. The Phase II objectives are to: 1) Complete Additional Refinements to Enhance Performance and Economy of Sensor Features 2) Develop Second Generation of Wireless Data Transmittal and Automated Data Analysis. 3) Design WrisTAS" 7 Enclosures (sensor module, electronics module and wristband/cable) 4) Evaluate the New WrisTAS" Products in Clinical Settings. Commercial Potential: There are a number of markets for a continuous, nohinvasive alcohol monitor including: 1) Research and clinical treatment programs. 2) Emergency room setting for individualsthat are unconscious, incapacitated, or unable to exhale forcibly. 3) Monitoring of professionals with or without known alcohol problems in positions involving public safety (aviation, nuclear, medical). 4) Monitoring drivers with prior DWI/DUI convictions. 5) Criminal justice system, where the court needs to monitor alcohol abstinence of convicted criminals on parole, probation or house arrest.